Dr. Teresa Clements Cunningham, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Heritage Rd Ste 100, Golden, CO 80401 Phone: 720-613-2357 |
Dr. Steven D Vath, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 725 Heritage Rd Ste 100, Golden, CO 80401 Phone: 303-278-2600 Fax: 303-278-4841 |
Dr. Adam Scott Levy, MD Plastic Surgery - Plastic Surgery Within the Head and Neck Medicare: May Accept Medicare Assignments Practice Location: 2801 Youngfield St Ste 371, Golden, CO 80401 Phone: 303-954-8878 |
Dr. Andrew J Wolfe, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 725 Heritage Rd Ste 100, Golden, CO 80401 Phone: 303-278-2600 Fax: 303-278-4841 |
Dr. Christopher Pell Fender, MD Plastic Surgery - Surgery of the Hand Medicare: May Accept Medicare Assignments Practice Location: 2801 Youngfield St, Suite 371, Golden, CO 80401 Phone: 303-954-8878 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Salivary mucins, key components of mucus, actively protect the teeth from the cariogenic bacterium, Streptococcus mutans, according to research published ahead of print in Applied and Environmental Microbiology. The research suggests that bolstering native defenses might be a better way to fight dental caries than relying on exogenous materials, such as sealants and fluoride treatment, says first author Erica Shapiro Frenkel, of Harvard University, Cambridge, MA.
Researchers have discovered how a genetic disease known mainly for its life-threatening tumors also can cause sudden death from cardiovascular disease in children, and are mounting a clinical trial to develop treatments for the problem.
Novartis today announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease (COPD) patients from Seretide (salmeterol/fluticasone) 50/500 mcg to Ultibro Breezhaler (indacaterol/glycopyrronium) 110/50 mcg.
› Verified 7 days ago